Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. European Lung Cancer Congress 2022

Duration of IO: Limited vs forever

Introduction and first vote

Date

02 Apr 2022

Session

Duration of IO: Limited vs forever

Topics

Immunotherapy

Tumour Site

Presenters

Suresh Ramalingam

Authors

S.S. Ramalingam

Author affiliations

  • Winship Cancer Institute of Emory University, Atlanta/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Limited

Presenter: Benjamin Besse

Session: Duration of IO: Limited vs forever

Resources:

Slides

Webcast

Forever

Presenter: Helena Linardou

Session: Duration of IO: Limited vs forever

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.